Skip to main content
Top
Published in: European Journal of Nutrition 8/2019

Open Access 01-12-2019 | Original Contribution

A pilot dose–response study of the acute effects of haskap berry extract (Lonicera caerulea L.) on cognition, mood, and blood pressure in older adults

Authors: Lynne Bell, Claire M. Williams

Published in: European Journal of Nutrition | Issue 8/2019

Login to get access

Abstract

Purpose

Haskap (Lonicera caerulea L. or blue honeysuckle) is a plant native to the low-lying wet areas and mountains of Siberia and northeastern Asia, but is now cultivated in Canada. The dark blue berries are rich in anthocyanins, particularly cyanidin-3-O-glucoside. Previously, anthocyanin-rich fruits have been observed to benefit cognitive performance during the immediate postprandial period following a single acute dose. However, no study has currently examined the potential for haskap berries to influence cognitive performance. Here, we investigate the acute cognitive benefits of an anthocyanin-rich haskap berry extract.

Methods

A double-blind, counterbalanced, crossover intervention study compared the acute effects of three separate haskap berry extract doses, containing 100 mg, 200 mg, and 400 mg anthocyanins, with a sugar-matched placebo. Participants were an opportunity sample of 20 older adults, aged 62–81 years. Measures of cognition, mood, and blood pressure were recorded at baseline and 1.5 h postprandially.

Results

Compared to placebo, the 400 mg dose elicited significantly lower diastolic blood pressure and heart rate. Both 200 mg and 400 mg doses elicited significantly higher word recall, with the 400 mg dose also significantly improving word recognition scores, on an episodic memory task. However, mood, working memory and executive function task results were more equivocal.

Conclusions

The findings provide evidence for improvements in episodic memory and blood pressure following acute supplementation with haskap berry extract, with higher doses appearing most effective. The cognitive findings concur with previous literature that suggests episodic memory effects, and not executive function effects, are most prevalent in older adults following anthocyanin-rich berry supplementation. The blood pressure outcome is consistent with a vasodilatory mechanism of action.
Literature
11.
go back to reference Whyte AR, Cheng N, Fromentin E, Williams C (2018) A randomized, double-blinded, placebo-controlled study to compare the safety and efficacy of low dose enhanced wild blueberry powder and wild blueberry extract (ThinkBlueTM) in maintenance of episodic and working memory in older adults. Nutrients 10:660. https://doi.org/10.3390/nu10060660 CrossRefPubMedCentral Whyte AR, Cheng N, Fromentin E, Williams C (2018) A randomized, double-blinded, placebo-controlled study to compare the safety and efficacy of low dose enhanced wild blueberry powder and wild blueberry extract (ThinkBlueTM) in maintenance of episodic and working memory in older adults. Nutrients 10:660. https://​doi.​org/​10.​3390/​nu10060660 CrossRefPubMedCentral
16.
go back to reference Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment, 5th edn. Oxford University Press, Oxford Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment, 5th edn. Oxford University Press, Oxford
18.
go back to reference Scholey AB, Harper S, Kennedy DO (2001) Cognitive demand and blood glucose. Physiol Behav 73:585–592CrossRef Scholey AB, Harper S, Kennedy DO (2001) Cognitive demand and blood glucose. Physiol Behav 73:585–592CrossRef
20.
go back to reference Eriksen CW (1995) The flankers task and response competition: a useful tool for investigating a variety of cognitive problems. Vis Cogn 2:101–118CrossRef Eriksen CW (1995) The flankers task and response competition: a useful tool for investigating a variety of cognitive problems. Vis Cogn 2:101–118CrossRef
26.
27.
go back to reference Tabachnick BG, Fidell LS (2013) Using multivariate statistics, 6th edn. Pearson, Boston Tabachnick BG, Fidell LS (2013) Using multivariate statistics, 6th edn. Pearson, Boston
29.
go back to reference Rouch L, Cestac P, Hanon O, Cool C, Helmer C, Bouhanick B, Chamontin B, Dartigues JF, Vellas B, Andrieu S (2015) Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 29:113–130. https://doi.org/10.1007/s40263-015-0230-6 CrossRefPubMed Rouch L, Cestac P, Hanon O, Cool C, Helmer C, Bouhanick B, Chamontin B, Dartigues JF, Vellas B, Andrieu S (2015) Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 29:113–130. https://​doi.​org/​10.​1007/​s40263-015-0230-6 CrossRefPubMed
35.
go back to reference Dodd GF (2012) The acute effects of flavonoid-rich blueberries on cognitive function in healthy younger and older adults. University of Reading, Reading Dodd GF (2012) The acute effects of flavonoid-rich blueberries on cognitive function in healthy younger and older adults. University of Reading, Reading
36.
go back to reference Cox KH, Pipingas A, Scholey AB (2015) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol 29:642–651CrossRef Cox KH, Pipingas A, Scholey AB (2015) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol 29:642–651CrossRef
Metadata
Title
A pilot dose–response study of the acute effects of haskap berry extract (Lonicera caerulea L.) on cognition, mood, and blood pressure in older adults
Authors
Lynne Bell
Claire M. Williams
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 8/2019
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1877-9

Other articles of this Issue 8/2019

European Journal of Nutrition 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.